相关实验视频

Updated: Feb 28, 2026

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms

Published on: May 31, 2024

基于SuFEx的结构辅助设计的LuxR型定数感应潜在抑制剂:共价或竞争性抑制?

Laurent Soulère¹, Sylvie Reverchon², Jessica Baude²

¹INSA LYON, CPE Lyon, Institut de Chimie et Biochimie Moléculaires et Supramoléculaires (ICBMS), Universite de Lyon 1, CNRS, UMR 5246, Bâtiment Lederer, 1 rue Victor Grignard, F-69622 Villeurbanne, France.

|February 27, 2026

概括

新的fluorosulfonyl-benzoyl-acylhomoserine乳衍生物显示出作为竞争力质量检测 (QS) 抑制剂的前景. 这些化合物有效地阻断了细菌的交流,提供了潜在的抗菌策略.

科学领域:

药用化学医学化学
分子生物学分子生物学
生物化学生物化学

背景情况:

定数感应 (QS) 是一种细胞间通信机制,对细菌毒性至关重要.
卢克斯R型受体调节QS系统,使其成为抗菌药物开发的有吸引力的目标.
乙烯基荷莫塞林乳 (AHL) 的类似物通常用作QS抑制剂.

研究的目的:

设计,合成和评估作为QS抑制剂的新型N-基-l-同素乳衍生物.
研究这些新型化合物的作用机制.
评估硫基替代剂在增强QS抑制方面的潜力.

主要方法:

合成N-基-l-同素乳衍生物与甲基-硫或甲基-甲基-硫基.
用LuxR型受体进行分子对接模拟.
在体外对抑制活性进行生物评估 (IC50测定).
使用19F NMR和LC/MS分析进行的动态研究,以阐明作用机制.

主要成果:

甲-硫尼尔衍生物具有显著的QS抑制活性,IC50为15 ± 2μM.
甲基硫尼尔衍生物显示出弱抑制作用.
证实了硫烯基衍生物的稳定性.
实验证据强烈表明存在竞争性抑制机制.

结论:

含有甲硫基的N-基-l-同素乳衍生物是LuxR调节的定数感应的有效竞争性抑制剂.
硫基替代剂在受体活性部位内的结合相互作用中起着关键作用.
这些发现凸显了含硫酸的AHL类似物作为针对细菌传播的新型抗菌剂的潜力.

关键词:

这就是为什么LuxR LuxR.SuFEx SuFEx 是一个然后点击化学.抑制剂抑制剂的使用议员数量检测是指对议员数量进行检测.泰洛辛 (tyrosine) 是一种蛋白质.

更多相关视频

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds

Published on: August 8, 2025

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Published on: January 1, 2016

相关概念视频

Gene Regulation in Microbial Communities: Quorum Sensing

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Bacterial Signaling

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...